False Claims Act - G2 Intelligence

Labs in Court: A Full Circle

Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

Start a Free Trial for immediate access to this article

Already a member? Log in here

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Start a Free Trial for immediate access to this article

Already a member? Log in here